Published in Proc Natl Acad Sci U S A on November 01, 1974
A molecular description of nerve terminal function. Annu Rev Biochem (1983) 1.82
Tyrosine hydroxylase regulation in the central nervous system. Mol Cell Biochem (1983) 0.89
Activation by cyclic 3':5'-adenosine monophosphate of tyrosine hydroxylase in the rat brain. Proc Natl Acad Sci U S A (1975) 0.79
Electrical stimulation increases phosphorylation of tyrosine hydroxylase in superior cervical ganglion of rat. Proc Natl Acad Sci U S A (1984) 0.76
Chronically lowering sympathetic activity protects sympathetic nerves in spleens from aging F344 rats. J Neuroimmunol (2012) 0.75
Noradrenaline synthesis after sympathetic nerve activation in rat atria and its dependence on calcium but not CAM kinase II and protein kinases A or C. Br J Pharmacol (1996) 0.75
Tetrahydrobiopterin increases in adrenal medulla and cortex: a factor in the regulation of tyrosine hydroxylase. Proc Natl Acad Sci U S A (1981) 0.75
Statistical estimations in enzyme kinetics. Biochem J (1961) 36.26
The determination of enzyme inhibitor constants. Biochem J (1953) 27.58
TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS. J Biol Chem (1964) 5.40
PREGANGLIONIC AND POSTGANGLIONIC STIMULATION OF THE GUINEA-PIG ISOLATED VAS DEFERENS PREPARATION. Br J Pharmacol Chemother (1963) 4.66
Solubilization and partial purification of tyrosine hydroxylase from bovine adrenal medulla. J Biol Chem (1971) 2.85
Acceleration of noradrenaline biosynthesis in the guinea-pig vas deferens by potassium. Br J Pharmacol (1970) 1.64
Inhibitors of purified beef adrenal tyrosine hydroxylase. Biochem Pharmacol (1965) 1.60
Tyrosine hydroxylase in rat brain--cofactor requirements, regional and subcellular distribution. Biochem Pharmacol (1972) 1.49
The regulation of norepinephrine synthesis in sympathetic nerves: effect of nerve stimulation, cocaine, and catecholamine-releasing agents. Proc Natl Acad Sci U S A (1966) 1.43
End-product inhibition of tyrosine hydroxylase as a possible mechanism for regulation of norepinephrine synthesis. Mol Pharmacol (1967) 1.31
Regulation of norepinephrine biosynthesis. Annu Rev Pharmacol (1970) 1.29
Acceleration of noradrenaline biosynthesis by nerve stimulation. Life Sci (1966) 1.23
The effect of nerve stimulation on the synthesis and metabolism of norepinephrine in the isolated guinea-pig hypogastric nerve-vas deferens preparation. J Pharmacol Exp Ther (1968) 1.20
A kinetic study of bovine adrenal tyrosine hydroxylase. J Biol Chem (1966) 1.17
Acceleration of norepinephrine synthesis in the rat submaxillary gland in vivo during sympathetic nerve stimulation. Life Sci (1967) 1.15
Increased synthesis of norepinephrine in the rat heart on electrical stimulation of the stellate ganglia. Mol Pharmacol (1966) 1.07
Factors influencing the rate of norepinephrine biosynthesis in nerve tissue. J Pharmacol Exp Ther (1967) 1.00
Regulation of noradrenaline biosynthesis in nerve tissue. Nature (1967) 0.92
Effect of drugs on the synthesis of noradrenaline in guinea-pig vas deferens. Br J Pharmacol (1972) 0.89
Further studies on the increased synthesis of norepinephrine during nerve stimulation of guinea-pig vas deferens preparation: effect of tyrosine and 6, 7-dimethyltetrahydropterin. J Pharmacol Exp Ther (1973) 0.84
Effect of calcium, sodium and potassium on adrenal tyrosine hydroxylase activity in vitro. Biochem Pharmacol (1972) 0.79
Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol (1989) 4.96
The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology (1999) 3.78
Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med (1992) 2.39
Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation. Br J Pharmacol (1971) 2.17
Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther (1973) 2.05
Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science (1997) 2.01
Controlled release of dopamine from a polymeric brain implant: in vivo characterization. Ann Neurol (1989) 2.01
Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc Natl Acad Sci U S A (1996) 1.66
Acceleration of noradrenaline biosynthesis in the guinea-pig vas deferens by potassium. Br J Pharmacol (1970) 1.64
Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones. Nat New Biol (1973) 1.61
Selective reduction of tryptophan hydroxylase activity in rat forebrain after midbrain raphe lesions. Brain Res (1971) 1.54
The determinants of stress-induced activation of the prefrontal cortical dopamine system. Prog Brain Res (1990) 1.45
Choline: selective accumulation by central cholinergic neurons. J Neurochem (1973) 1.45
Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease. Exp Neurol (1997) 1.43
Susceptibility to a parkinsonian toxin varies during primate development. Exp Neurol (2012) 1.41
Fetal neural graft survival. Lancet (1990) 1.40
Comment on Roth appliance. Am J Orthod Dentofacial Orthop (1993) 1.39
Spontaneous blink rates correlate with dopamine levels in the caudate nucleus of MPTP-treated monkeys. Exp Neurol (1999) 1.38
Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat. J Neurosci (1996) 1.38
Variations in noradrenaline output with respect to stimulus frequency, train length and origin of the transmitter. Br J Pharmacol (1972) 1.32
Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory. J Neurosci (2000) 1.30
Pharmacology of mesocortical dopamine neurons. Pharmacol Rev (1983) 1.27
Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology (1997) 1.25
Mechanism of the gamma-hydroxybutyrate-induced increase in brain dopamine and its relationship to "sleep". Biochem Pharmacol (1970) 1.24
Acceleration of noradrenaline biosynthesis by nerve stimulation. Life Sci (1966) 1.23
Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons. Neuroscience (1984) 1.22
Dialytrode for long term intracerebral perfusion in awake monkeys. Arch Int Pharmacodyn Ther (1972) 1.21
Variation in noradrenaline output with changes in stimulus frequency and train length: role of different noradrenaline pools. Br J Pharmacol (1974) 1.19
The action of reserpine on noradrenaline biosynthesis in sympathetic nerve tissue. Biochem Pharmacol (1968) 1.16
In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. Gene Ther (1998) 1.16
Nicotine receptor inactivation decreases sensitivity to cocaine. Neuropsychopharmacology (2001) 1.13
The role of mesoprefrontal dopamine neurons in the acquisition and expression of conditioned fear in the rat. Neuroscience (1999) 1.13
Telencephalic projections of the A8 dopamine cell group. Ann N Y Acad Sci (1988) 1.13
Autoreceptor regulation of dopamine synthesis. Ann N Y Acad Sci (1990) 1.12
Cocaethylene: a neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion. Life Sci (1991) 1.10
The predator odor, TMT, displays a unique, stress-like pattern of dopaminergic and endocrinological activation in the rat. Brain Res (2000) 1.09
Dopamine and spatial working memory in rats and monkeys: pharmacological reversal of stress-induced impairment. J Neurosci (1996) 1.09
Functional occlusion for the orthodontist. J Clin Orthod (1981) 1.09
Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action. Prog Brain Res (2000) 1.07
Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res (1990) 1.07
Gamma-hydroxybutyrate-induced increase in brain dopamine: localization by fluorescence microscopy. J Pharmacol Exp Ther (1970) 1.06
Content and release of amino-acids and catecholamines in monkey brain. Nature (1969) 1.06
Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Lancet (1986) 1.06
Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment. Neuroscience (2000) 1.05
Cocaine increases extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdialysis. Neurosci Lett (1989) 1.05
Evidence that central nervous system depression by 1,4-butanediol in mediated through a metabolite, gamma-hydroxybutyrate. Biochem Pharmacol (1968) 1.04
The straight-wire appliance 17 years later. J Clin Orthod (1987) 1.04
Increased turnover of norepinephrine in the rat cerebral cortex during stress: role of the locus coeruleus. Neuropharmacology (1973) 1.02
D1 and D2 dopamine receptors independently regulate spontaneous blink rate in the vervet monkey. J Pharmacol Exp Ther (1991) 1.02
GABA levels in CSF of patients with psychiatric disorders. Am J Psychiatry (1980) 1.02
Light and heavy norepinephrine storage particles in the rat heart and in bovine splenic nerve. J Pharmacol Exp Ther (1968) 1.02
Dopaminergic neurons: similar biochemical and histochemical effects of gamma-hydroxybutyrate and acute lesions of the nigro-neostriatal pathway. J Pharmacol Exp Ther (1973) 1.01
An antisense oligonucleotide reverses the footshock-induced expression of fos in the rat medial prefrontal cortex and the subsequent expression of conditioned fear-induced immobility. J Neurosci (1999) 1.01
Evidence for involvement of protein kinase in the activation by adenosine 3':5'-monophosphate of brain tyrosine 3-monooxygenase. J Biol Chem (1975) 1.01
Factors influencing the rate of norepinephrine biosynthesis in nerve tissue. J Pharmacol Exp Ther (1967) 1.00
Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal. Psychopharmacology (Berl) (1988) 1.00
Regulation of catecholamine synthesis in the rat brain in vitro by cyclic AMP. Nature (1974) 1.00
Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid. Eur J Pharmacol (1976) 0.99
Effect of anesthetic doses of hydroxybutyrate on subcortical concentrations of homovanillic acid. Eur J Pharmacol (1971) 0.98
Footshock and conditioned stress increase 3,4-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substantia nigra. Brain Res (1985) 0.97
Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys. Eur J Pharmacol (1991) 0.97
Delta 9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: blockade of dopaminergic effects with HA966. Neuropsychopharmacology (1997) 0.97
Nicotinic modulation of mesoprefrontal dopamine neurons: pharmacologic and neuroanatomic characterization. J Pharmacol Exp Ther (2000) 0.96
Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors. Naunyn Schmiedebergs Arch Pharmacol (1976) 0.96
TMT, a predator odor, elevates mesoprefrontal dopamine metabolic activity and disrupts short-term working memory in the rat. Brain Res Bull (2000) 0.96
Postmortem stability of monoamines, their metabolites, and receptor binding in rat brain regions. J Neurochem (1994) 0.95
Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: biochemical changes in striatal regions. Neuroscience (1989) 0.95
Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus). Neuroscience (1997) 0.95
Dopamine autoreceptors: pharmacology, function and comparison with post-synaptic dopamine receptors. Commun Psychopharmacol (1979) 0.95
Enhanced release of transmitter during sympathetic nerve stimulation in the presence of angiotensin. Br J Pharmacol (1969) 0.94
Angiotensin accelerates catecholamine biosynthesis in sympathetically innervated tissues. Nature (1969) 0.93
Dopaminergic neurons: effects of electrical stimulation on dopamine biosynthesis. Mol Pharmacol (1976) 0.93
Characterization of dopamine release in the rat medial prefrontal cortex as assessed by in vivo microdialysis: comparison to the striatum. Neuroscience (1990) 0.93
Cocaine and cocaethylene: microdialysis comparison of brain drug levels and effects on dopamine and serotonin. J Neurochem (1993) 0.92
Embryonic substantia nigra grafts in the mesencephalon send neurites to the host striatum in non-human primate after overexpression of GDNF. J Comp Neurol (2009) 0.92
Regulation of noradrenaline biosynthesis in nerve tissue. Nature (1967) 0.92
Engagement in a non-escape (displacement) behavior elicits a selective and lateralized suppression of frontal cortical dopaminergic utilization in stress. Synapse (1999) 0.92
Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys. Brain (1990) 0.91
Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys. Psychopharmacology (Berl) (1999) 0.91
5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex. Neuropsychopharmacology (1999) 0.91
FDA's priority-based assessment of food additives. I. Preliminary results. Regul Toxicol Pharmacol (1984) 0.91
Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls. Exp Brain Res (1991) 0.91
Impact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson's disease. Neuroscience (2011) 0.90
Cognitive and motor deficits in the performance of an object retrieval task with a barrier-detour in monkeys (Cercopithecus aethiops sabaeus) treated with MPTP: long-term performance and effect of transparency of the barrier. Behav Neurosci (1990) 0.90
Formation and regional distribution of gamma-hydroxybutyric acid in mammalian brain. Biochem Pharmacol (1970) 0.90
In vivo assessment of basal and drug-induced dopamine release in cortical and subcortical regions of the anesthetized primate. Synapse (1993) 0.90
Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion. Neuropsychopharmacology (1998) 0.90
Cryopreservation of human brain tissue. Exp Neurol (1990) 0.90
Neural stem cells implanted into MPTP-treated monkeys increase the size of endogenous tyrosine hydroxylase-positive cells found in the striatum: a return to control measures. Cell Transplant (2005) 0.90
Regulation of excitatory amino acid release by N-methyl-D-aspartate receptors in rat striatum: in vivo microdialysis studies. Brain Res (1992) 0.90
Synaptosomes from forebrains of rats with midbrain raphe lesions: selective reduction of serotonin uptake. J Pharmacol Exp Ther (1972) 0.90
Individual differences in behavioral measures: correlations with nucleus accumbens dopamine measured by microdialysis. Pharmacol Biochem Behav (1991) 0.89
Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioral and neurochemical evidence. Psychopharmacology (Berl) (1998) 0.89
Effects of D2 dopamine receptor antagonists on Fos protein expression in the striatal complex and entorhinal cortex of the nonhuman primate. Synapse (1996) 0.89
Stress-induced activation of prefrontal cortex dopamine turnover: blockade by lesions of the amygdala. Brain Res (1994) 0.89
Effect of drugs on the synthesis of noradrenaline in guinea-pig vas deferens. Br J Pharmacol (1972) 0.89
Panic-induced elevation of plasma MHPG levels in phobic-anxious patients. Effects of clonidine and imipramine. Arch Gen Psychiatry (1983) 0.89
Object retrieval/detour deficits in monkeys produced by prior subchronic phencyclidine administration: evidence for cognitive impulsivity. Biol Psychiatry (2000) 0.89